BridgeMD
Compares treatment options for Suspected Sarcoidosis
Official title Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis
ClinicalTrials.gov ID: NCT06220526
What this study is testing
- What it's testing
- This randomized pilot clinical trial aims to examine whether sample collection with Franseen-type needles are effective for the diagnosis of sarcoidosis, as defined by improved sample quality for pathological diagnosis compared to the conventional Menghini-type needle.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- -Any adult patient aged 18 years or older with enlarged mediastinal and/or hilar lymph nodes
- (≥10 mm short-axis diameter on a CT scan), suspected as having sarcoidosis based on clinical
- history, physical exam, and other investigations, and booked for EBUS-TBNA.
You likely can't join if
- -Patients that are unable to provide informed consent \- Patients with lymphadenopathy strongly suspected to be secondary to other diseases based on
- clinical history, physical exam, and/or other investigations (e.g., lung cancer, lymphoma,
- infection).
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.